Other substances

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]oxane-3,4,5-triol

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]oxane-3,4,5-triol on PubChem

Synonyms

MolPort-005-945-924; beta-D-Glucosylisoeugenol

 

Structure image - (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-[2-methoxy-4-[(E)-prop-1-enyl]phenoxy]oxane-3,4,5-triol

C/C=C/C1=CC(=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC

Supporting references

Link Tested on Impact factor Notes Publication date
Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling
3CLpro Small molecule In silico 		in silico 3.31

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Aug/14/2020
Export (.csv)